Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 19 Neoplasms 7 Breast Neoplasms 5 Pancreatic Neoplasms 4 Hematologic Neoplasms 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Carcinoma, Non-Small-Cell Lung 3 Brain Neoplasms 3 Thyroid Carcinoma, Anaplastic 2 Thyroid Cancer, Papillary 2 Sarcoma 2 Prostatic Neoplasms 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Gastrointestinal Neoplasms 2 Erdheim-Chester Disease 2 Colorectal Neoplasms 2 Xanthogranuloma, Juvenile 1 Thyroid Neoplasms 1 Thrombocytosis 1 Solid Tumor 1 Skin Neoplasms 1 Sarcoma, Clear Cell 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Fluorodeoxyglucose F18 7 Irinotecan 4 Fluorouracil 4 Cyclophosphamide 4 Bevacizumab 4 toripalimab 3 pembrolizumab 3 olaparib 3 Radiosurgery 3 Cisplatin 3 Capecitabine 3 vistusertib 2 tislelizumab 2 spartalizumab 2 fludarabine 2 atezolizumab 2 apatinib 2 Temozolomide 2 Technetium 2 Specimen Handling 2 Sirolimus 2 Radiotherapy 2 Proton Therapy 2 Paclitaxel 2 Leucovorin 2 Letrozole 2 Hydroxychloroquine 2 Everolimus 2 Drug Therapy 2 Docetaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Solid Tumor × cobimetinib × Clear all

NCT04185831 2024-08-22

MEGALiT

Uppsala University Hospital

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡